Dr. Igor Kovalchuk. (University of Lethbridge) U of L: New medical cannabis cultivars show promise in combatting COVID-19 Apr 22, 2020 10:18 AM

LETHBRIDGE, AB – Researchers at the University of Lethbridge, along with their partners, have found that specific cannabis sativa extracts are showing promise as an additional treatment for COVID-19.

Scientists at the university worked alongside Pathway RX, a research firm focused on developing custom cannabis therapies, and Swysh, a company focused on cannabinoid research and development.

“While our most successful extracts require further validation in a large-scale analysis and an animal model, our study is crucial for the future analysis of the effects of medical cannabis on COVID-19,” says Dr. Igor Kovalchuk, a U of L biology professor and CEO of Pathway RX.

Kovalchuck and a team of researchers have submitted a paper on their research about the effects of medical cannabis on the virus, although it has yet to be peer-reviewed or published in a journal.